Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Massachusetts General Hospital
University of Pennsylvania
National Cancer Institute (NCI)
Northwestern University
M.D. Anderson Cancer Center
ProCure Proton Therapy Center
Washington University School of Medicine
University of Washington
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital Identifier:
First received: June 8, 2012
Last updated: November 5, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)